10:26 AM EST - Avicanna Inc. : Has entered into an agreement whereby Avicanna will develop certain hemp-derived cannabinoid-based products including sublingual and sustained released tablets intended for the sleep market for a U.S. distributor. Avicanna Inc.
shares T.AVCN are trading down $0.06 at $0.95.
